Status:
COMPLETED
Web-based Tailored Information and Support for Patients With a Neuroendocrine Tumor: a Randomized Pilot Study
Lead Sponsor:
University Medical Center Groningen
Conditions:
Distress
Quality of Life
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Background Physical as well as psychosocial complaints are frequently present in patients with a neuroendocrine tumor (NET). Adequate information is seen as an essential aspect of supportive care. The...
Eligibility Criteria
Inclusion
- Adult NET patients (aged ≥ 18 years of age) with any tumor site and disease stage.
- Ability to comprehend Dutch (both reading and writing).
- Informed consent provided.
Exclusion
- Estimated life expectancy less than 3 months.
- Patients with a second primary tumor for which active follow-up or treatment.
Key Trial Info
Start Date :
October 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2014
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01849523
Start Date
October 1 2013
End Date
August 1 2014
Last Update
May 6 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Spectrum Twente
Enschede, Netherlands
2
University Medical Center Groningen
Groningen, Netherlands, 9713 GZ